Protocol for investigating the impact of transcription regulator deficiency on tumor-specific CD8+ T cell responses via adoptive cell transfer
Transcription factors play a crucial role in the differentiation of tumor-specific CD8<sup>+</sup> T cells and significantly influence their capacity to repress tumors. Here, we present a protocol for creating a transcription regulator inhibitor of DNA 3 (ID3) conditional knockout mouse in tumor-specific CD8<sup>+</sup> T cells, induced by tamoxifen. We describe steps for examining the impact of ID3 deficiency on the differentiation of tumor-specific memory CD8<sup>+</sup> T cells (Ttsm) and progenitors of exhausted CD8<sup>+</sup> T cells (Tpex) in tumor-draining lymph nodes through a co-adoptive transfer assay. For complete details on the use and execution of this protocol, please refer to Ran et al.<sup>1</sup>.
Authors
- Mengqu Ran
- Luming Xu (ORCID: https://orcid.org/0000-0002-3746-1332)
- Lilin Ye (ORCID: https://orcid.org/0000-0003-0778-3311)
- Wen Liu (ORCID: https://orcid.org/0000-0003-3434-4162)
- Yuzhu Wang (ORCID: https://orcid.org/0000-0002-0230-5452)
- Qizhao Huang
Institutions
- Army Medical University (CN)
- Southern Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- STAR Protocols
- Published
- 2025-03-26
- DOI
- https://doi.org/10.1016/j.xpro.2025.103703
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00